STIMNeuronetics, Inc.vs its industry peers
A metric-by-metric comparison of Neuronetics, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STIMThis | $171M#6 | — | 9.6x#5 | 1.1x#1 | 99.2%#1 | 10.8%#4 | -21.1%#5 | -218.5%#6 | -43.9%#5 | 3#4 | — | — |
| ANIK | $257M#1 | — | 1.9x#3 | 2.3x#4 | -5.9%#4 | 80.4%#3 | -9.8%#4 | -8.0%#4 | -8.8%#3 | 4#3 | 95.1%#1 | — |
| INFU | $248M#2 | 31.1x#3 | 4.2x#4 | 1.7x#2 | 6.4%#2 | 182.6%#2 | 8.3%#3 | 11.2%#2 | 9.5%#2 | 9#1 | — | — |
| OSUR | $247M#3 | — | 0.8x#1 | 2.1x#3 | -38.1%#6 | -252.5%#6 | -62.6%#6 | -21.6%#5 | -43.8%#4 | — | — | — |
| IDXG | $240M#4 | 9.9x#1 | 10.3x#6 | 6.2x#6 | -17.5%#5 | 267.2%#1 | 10.5%#2 | 105.8%#1 | 14.2%#1 | 5#2 | — | — |
| UTMD | $226M#5 | 21.6x#2 | 1.8x#2 | 5.9x#5 | -5.8%#3 | -18.7%#5 | 29.6%#1 | 9.2%#3 | — | — | — | 1.8%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice